Results 41 to 50 of about 8,269 (200)

Mutations of ETNK1 in aCML and CMML [PDF]

open access: yesBlood, 2015
In this issue of Blood , Gambacorti-Passerini et al describe, for the first time, mutations of an ethanolamine kinase called ETNK1, which is physiologically involved in the first step of the phosphatidylethanolamine biosynthesis pathway. 1 The authors describe 2 recurrent point mutations of ETNK1 in 9% of atypical chronic myeloid leukemias (aCMLs ...
openaire   +2 more sources

Clinical Outcomes of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CMML) and Predictive Factors of Evolution of OM-CMML into Overt Chronic Myelomonocytic Leukemia (CMML)

open access: yesBlood, 2021
Abstract INTRODUCTION Recent studies have shown that OM-CMML and CMML have a similar clinical and biological profile. Since the proliferative-CMML (P-CMML) is the last-stage of CMML proliferative continuum and shows poor outcomes, it is expected that OM-CMML presents the best outcomes of these entities, as it represents an
David Roman-Bravo   +11 more
openaire   +1 more source

Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy. [PDF]

open access: yes, 2023
Myelodysplastic Neoplasms (MDS) and Chronic Myelomonocytic Leukemia (CMML) are clonal disorders driven by progressively acquired somatic mutations in hematopoietic stem cells (HSCs).
Zanini, Fabio   +25 more
core   +1 more source

Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis

open access: yesFrontiers in Oncology
IntroductionChronic myelomonocytic leukemia (CMML) and myelodysplastic syndromes (MDS) with ring sideroblasts (RS) or SF3B1 mutation (MDS-RS/SF3B1) differ in many clinical features, but share others, such as anemia.
Blanca Xicoy   +20 more
doaj   +1 more source

Massive Right Atrial Thrombosis: Are You Brave Enough to Start Anticoagulation? A Case Report

open access: yesFrontiers in Cardiovascular Medicine, 2021
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder with overlapping myelodysplastic and myeloproliferative features.
Marco Bergonti   +6 more
doaj   +1 more source

CHRONIC MYELOMONOCYTIC LEUKEMIA - REVIEW AND CLINICAL EXPERIENCE OF THE HEMATOLOGY DEPARTMENT UMHAT "ST. MARINA" - VARNA [PDF]

open access: yesJournal of IMAB, 2016
Chronic myelomonocytic leukemia (CMML) is a rare de novo myeloid neoplasm that exhibits dysplastic and proliferative features at presentation. The diagnosis is problematic with several specific controversial issues.
Ilina Micheva   +3 more
doaj   +1 more source

Chronic myelomonocytic leukemia as a transformation from polycythemia vera

open access: yesLeukemia Research Reports, 2019
The hallmark of Polycythemia vera (PV) is the presence of JAK2V617F mutation and increased RBC mass. Chronic myelomonocytic leukemia (CMML) is defined as persistent blood absolute monocyte count (AMC) >/= 1 × 109/L for at least 3 months with myeloid cell
Mirela Andrei   +3 more
doaj   +1 more source

Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

open access: yesFrontiers in Oncology, 2021
Chronic myelomonocytic leukemia (CMML) is a rare clonal haematological malignancy bearing characteristics of both myelodysplastic syndromes and myeloproliferative neoplasms. It primarily affects older people (median age at diagnosis ~72 years). There are
Konstantinos Liapis, Ioannis Kotsianidis
doaj   +1 more source

Allogeneic Hematopoietic Stem Cell Transplantation for MDS and CMML: When and How?

open access: yes, 2023
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only curative treatment in both MDS and CMML. In MDS, there is an increasing prevalence of high-risk MDS undergoing HSCT, whereas only a selected group of patients with low-risk ...
Gill, Harinder   +3 more
core   +1 more source

Allogeneic Transplant for CMML

open access: yesCurrent Hematologic Malignancy Reports
Abstract Purpose of Review Chronic myelomonocytic leukemia (CMML) is a rare hematologic malignancy at the intersection of myelodysplastic (MDS) and myeloproliferative neoplasms, predominantly affecting older adults.
Gagelmann, Nico, Desai, Nihar
openaire   +2 more sources

Home - About - Disclaimer - Privacy